Compounds > 2,2-bis(4-glycidyloxyphenyl)propane

2,2-bis(4-glycidyloxyphenyl)propane and luteolin

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with luteolin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abo-Warda, SM; El-Bassossy, HM; Fahmy, A	1

Other Studies

1 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and luteolin

Article	Year
Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation. The American journal of Chinese medicine, 2014, Volume: 42, Issue:5 Topics: Anilides; Animals; Aorta, Thoracic; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Epoxy Compounds; Flavonoids; Glycation End Products, Advanced; Hyperinsulinism; In Vitro Techniques; Insulin; Insulin Resistance; Lipids; Luteolin; Male; Muscle, Smooth, Vascular; Nitric Oxide; PPAR gamma; Rats; Reactive Oxygen Species; Vasoconstriction	2014

Article

Year

Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.

The American journal of Chinese medicine, 2014, Volume: 42, Issue:5

Topics: Anilides; Animals; Aorta, Thoracic; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Epoxy Compounds; Flavonoids; Glycation End Products, Advanced; Hyperinsulinism; In Vitro Techniques; Insulin; Insulin Resistance; Lipids; Luteolin; Male; Muscle, Smooth, Vascular; Nitric Oxide; PPAR gamma; Rats; Reactive Oxygen Species; Vasoconstriction

2014